Inhibitory effects of asiatic acid and CPT-11 on growth of HT-29 cells
-
- Bunpo Piyawan
- Department of Molecular Bacteriology, Institute of Health Biosciences, The University of Tokushima Graduate School Department of Biochemistry, Faculty of Medicine, Chiang Mai University
-
- Kataoka Keiko
- Department of Molecular Bacteriology, Institute of Health Biosciences, The University of Tokushima Graduate School
-
- Arimochi Hideki
- Department of Molecular Bacteriology, Institute of Health Biosciences, The University of Tokushima Graduate School
-
- Nakayama Haruyuki
- Department of Molecular Bacteriology, Institute of Health Biosciences, The University of Tokushima Graduate School
-
- Kuwahara Tomomi
- Department of Molecular Bacteriology, Institute of Health Biosciences, The University of Tokushima Graduate School
-
- Vinitketkumnuen Usanee
- Department of Biochemistry, Faculty of Medicine, Chiang Mai University
-
- Ohnishi Yoshinari
- Department of Molecular Bacteriology, Institute of Health Biosciences, The University of Tokushima Graduate School
この論文をさがす
説明
Asiatic acid is a pentacyclic triterpene contained in medicinal plants. The cytotoxic effect of this compound and its augmentative effect on the anticancer drug irinotecan hydrochloride (CPT-11) were investigated in the human colon adenocarcinoma cell line HT-29. Asiatic acid dose-dependently showed cytotoxicity in HT-29 cells. DNA fragmentation, annexin-positive apoptotic cells, and caspase-3 activation were observed in a dose-dependent manner. A caspase-3 inhibitor suppressed the DNA ladder formation in a concentration-dependent manner. Bcl-2 and Bcl-xL proteins were decreased by asiatic acid treatment. These results indicate that asiatic acid induced apoptosis in HT-29 cells via caspase-3 activation. Cytotoxic effects of combined treatment with CPT-11 and asiatic acid on HT-29 cells were further examined. Simultaneous treatment or sequential exposure first to asiatic acid and then to CPT-11 showed an additive effect. Synergism was observed when cells were first exposed to CPT-11 and then to asiatic acid. These results suggest that asiatic acid can be used as an agent for increasing sensitivity of colon cancer cells to treatment with CPT-11 or as an agent for reducing adverse effects of CPT-11. J. Med. Invest. 52: 65-73, February, 2005
収録刊行物
-
- The Journal of Medical Investigation
-
The Journal of Medical Investigation 52 (1,2), 65-73, 2005
国立大学法人 徳島大学医学部
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679221384192
-
- NII論文ID
- 130004465065
- 120006378385
- 110002253169
-
- NII書誌ID
- AA11166929
-
- ISSN
- 13496867
- 13431420
-
- PubMed
- 15751275
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- IRDB
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可